10x Genomics Raises FY2026 Sales Guidance from $610.000M-$630.000M to $625.000M-$635.000M vs $619.854M Est
Benzinga Newsdesk 1 day ago
NewsGuidance
10x Genomics (NASDAQ:TXG) raises FY2026 sales outlook from $610.000 million-$630.000 million to $625.000 million-$635.000 million vs $619.854 million estimate.
10x Genomics (NASDAQ:TXG) raises FY2026 sales outlook from $610.000 million-$630.000 million to $625.000 million-$635.000 million vs $619.854 million estimate.